Each of the PCCTC’s 13 cancer centers conduct multicenter phase I and II trials of novel drugs and novel drug combinations for the management of prostate cancer at all stages of the disease. Voluntary participation in a clinical trial gives one the opportunity to contribute to knowledge of, and progress against, cancer. PCCTC trials use a staging system known as the clinical states model to adjust treatment to each patient's evolving needs.